Axsome Therapeutics Inc (AXSM)
Cost of Revenue
$52.53M
TTM · Period ending: · USD
AXSM Cost of Revenue
Latest reported$52.53Mperiod ending
Latest reported$52.53Mperiod ending
AXSM TTM Cost of Revenue ($0.00 → $52.53M)
TTM cost of revenue
High-resolution chart · PNG
AXSM cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 52,530,000 | |
| 52,414,000 | |
| 47,478,000 | |
| 45,663,000 | |
| 42,188,000 | |
| 36,795,000 | |
| 33,303,000 | |
| 30,167,000 | |
| 28,262,000 | |
| 24,806,000 | |
| 26,065,000 | |
| 20,977,928 | |
| 16,369,928 | |
| 12,753,928 | |
| 5,197,928 | |
| 2,907,000 | |
| 983,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |